Li Yu's Insider Trades & SAST Disclosures
Li Yu's most recent trade in Opko Health Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Li Yu.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opko Health Inc | Alice Lin-Tsing Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Opko Health Inc | Alice Lin-Tsing Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Opko Health Inc | Alice Lin-Tsing Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Oncocyte Corporation | Li Yu | VP Cntrllr/Prncpl Acctng Offcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock, no par value | |
| Oncocyte Corporation | Li Yu | VP Cntrllr/Prncpl Acctng Offcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Oncocyte Corporation | Li Yu | VP Cntrllr/Prncpl Acctng Offcr | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 18 May 2022 | 8,128 | 16,872 (0%) | 0% | 1.1 | 9,266 | Common Stock, no par value |
| CBAK Energy Technology Inc | Yunfei Li | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Oncocyte Corporation | Li Yu | VP Cntrllr/Prncpl Acctng Offcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 37,500 | 37,500 | - | - | Option to Purchase Common Stock | |
| Oncocyte Corporation | Li Yu | VP Cntrllr/Prncpl Acctng Offcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 37,500 | 37,500 | - | - | Option to Purchase Common Stock | |
| Oncocyte Corporation | Li Yu | VP Cntrllr/Prncpl Acctng Offcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 160,000 | 160,000 | - | - | Option to Purchase Common Stock | |
| Opko Health Inc | Alice Lin-Tsing Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Apollo Medical Holdings Inc | Li Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Opko Health Inc | Alice Lin-Tsing Yu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Yunhong CTI Ltd | Yubao Li | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Jun 2020 | 50,000 | 500,000 | - | - | Series A Preferred Stock | |
| CBAK Energy Technology Inc | Yunfei Li | Director, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.48 per share. | 03 Jun 2020 | 2,062,619 | 10,726,705 (20%) | 3% | 0.5 | 990,057 | COMMON STOCK |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges